The molecular pathology of thyroid neoplasms

The molecular pathology of thyroid neoplasms

<p class="Pa19"><span>The Bethesda system of reporting thyroid cytology is being currently adopted worldwide. Rapid advances have been made in the understanding of the genetics of thyroid cancers. Common genetic mutations include RAS, BRAF, p53, B Catenin, and PAX8/PPAR&gam...

Full description

Bibliographic Details
Main Author:	JB Thapa
Format:	Article
Language:	English
Published:	Association of Clinical Pathologists of Nepal 2014-04-01
Series:	Journal of Pathology of Nepal
Subjects:	Thyroid Tumours Bethesda System RAS BRAF p53 B Catenin PAX8/PPAR? Biological behavior Gene therapy
Online Access:	http://www.nepjol.info/index.php/JPN/article/view/10317

Similar Items

Cytomorphology of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features and the Impact of New Nomenclature on Molecular Testing
by: Rupendra T. Shrestha, et al.
Published: (2019-01-01)

Molecular testing for BRAFV600E and RAS mutations from cytoscrapes of thyroid fine needle aspirates: A single-center pilot study
by: Ojas Gupta, et al.
Published: (2020-01-01)

Revised criteria for diagnosis of NIFTP reveals a better correlation with tumor biological behavior
by: Ana Carolina de Jesus Paniza, et al.
Published: (2019-12-01)

Genomic characterization of high-recurrence risk papillary thyroid carcinoma in a southern Chinese population
by: Min Li, et al.
Published: (2020-05-01)

A specific Translocation of Chromosome 3 Generating Pax8-PPARg Fusion mRNA is Rare in Japanese Patients with Follicular Carcinoma
by: HIBI, Yatsuka, et al.
Published: (2002)

Update on Fundamental Mechanisms of Thyroid Cancer
by: Alessandro Prete, et al.
Published: (2020-03-01)

Differentiated Thyroid Carcinoma in Pediatric Age: Genetic and Clinical Scenario
by: Francesca Galuppini, et al.
Published: (2019-08-01)

Diagnosis of thyroid neoplasms: state of the art on 2018
by: Vera A. Kachko, et al.
Published: (2018-12-01)

Genetic Determinants for Prediction of Outcome of Patients with Papillary Thyroid Carcinoma
by: Antónia Afonso Póvoa, et al.
Published: (2021-04-01)

Does the Bethesda category predict aggressive features in differentiated thyroid cancer?
by: Ana Rafaela Lopes Reis Lima, et al.

Implementation of Bethesda system in thyroid aspirate: A cyto-histopathological correlation study
by: PK Choudhary, et al.
Published: (2016-03-01)

Correlation between thyroid imaging reporting and data system and bethesda system of reporting of thyroid cytopathology of thyroid nodule: A single center experience
by: Ananya Biswas, et al.
Published: (2020-01-01)

Cytological diagnosis of pediatric thyroid nodule in perspective of the Bethesda System for Reporting Thyroid Cytopathology
by: Chayanika Pantola, et al.
Published: (2016-01-01)

Histopathological review of diagnostic categories of the Bethesda system for reporting thyroid cytopathology – An institutional experience of 5 years
by: Paricha Upadhyaya, et al.
Published: (2019-01-01)

The role of repeat fine needle aspiration in managing indeterminate thyroid nodules
by: Laura Allen, et al.
Published: (2019-03-01)

Approaching indeterminate thyroid nodules in the absence of molecular markers: “The BETH-TR score”
by: Sushma Mehta, et al.
Published: (2020-01-01)

Are Bethesda III Thyroid Nodules More Aggressive than Bethesda IV Thyroid Nodules When Found to Be Malignant?
by: Sena Turkdogan, et al.
Published: (2020-09-01)

Molecular Correlates and Nuclear Features of Encapsulated Follicular-Patterned Thyroid Neoplasms
by: Chan Kwon Jung, et al.
Published: (2021-02-01)

Thyroid and Parathyroid gland Pathology. The Bethesda System for Reporting Thyroid Cytopathology
by: Jesús PINTO-BLÁZQUEZ, et al.
Published: (2020-07-01)

BRAFV600E Mutation, RET/PTC1 and PAX8-PPAR Gamma Rearrangements in Follicular Epithelium Derived Thyroid Lesions - Institutional Experience and Literature Review
by: Ahmet Şahpaz, et al.
Published: (2015-06-01)

Characterization of Driver Mutations in Anaplastic Thyroid Carcinoma Identifies <i>RAS</i> and <i>PIK3CA</i> Mutations as Negative Survival Predictors
by: Wei-An Lai, et al.
Published: (2020-07-01)

Molecular mutations as a possible factor for determining extent of thyroid surgery
by: Joshua R. Krasner, et al.
Published: (2019-10-01)

FNAC accuracy in diagnosis of thyroid neoplasms considering all diagnostic categories of the Bethesda reporting system: A single-institute experience
by: Fatemeh Hajmanoochehri, et al.
Published: (2015-01-01)

Thyroid Cancer Detection in a Routine Clinical Setting: Performance of ACR TI-RADS, FNAC and Molecular Testing in Prospective Cohort Study
by: Bendlova, B., et al.
Published: (2022)

Thyroid nodules cytopathology applying the Bethesda system with histopathological correlation
by: Hawazen A Zarif, et al.
Published: (2018-01-01)

Intratumoral Heterogeneity in Differentiated Thyroid Tumors: An Intriguing Reappraisal in the Era of Personalized Medicine
by: Antonio Ieni, et al.
Published: (2021-04-01)

Causative Factors for ADHD: Role of Thyroid Stimulating Hormone Receptor in ADHD
by: J Gordon Millichap, et al.
Published: (2014-08-01)

Reproducibility of ‘The Bethesda System for reporting Thyroid Cytopathology’: A MultiCenter Study with Review of the Literature
by: Tejinder Singh Bhasin, et al.
Published: (2013-06-01)

Thyroid cancer among patients with thyroid nodules in Yemen: a three-year retrospective study in a tertiary center and a specialty clinic
by: Butheinah A. Al-Sharafi, et al.
Published: (2020-06-01)

Cancer Associated Fibroblasts and Senescent Thyroid Cells in the Invasive Front of Thyroid Carcinoma
by: Emanuela Minna, et al.
Published: (2020-01-01)

Malignancy rates in thyroid nodules classified as Bethesda categories III and IV; a subcontinent perspective
by: Adnan Zahid, et al.
Published: (2021-03-01)

Evaluation of thyroid nodules classified as Bethesda category III on FNAC
by: Shiwani Garg, et al.
Published: (2017-01-01)

Galectin-3 Immunohistochemical Expression in Thyroid Neoplasms
by: B S Sumana, et al.
Published: (2015-11-01)

Comparison of Immunohistochemistry and Direct Sanger Sequencing for Detection of the Mutation in Thyroid Neoplasm
by: Hye-Seon Oh, et al.
Published: (2018-01-01)

Is Bethesda classification sufficient to predict thyroid cancer in endemic regions?
by: Gamze Çıtlak, et al.
Published: (2020-09-01)

Molecular profiling of follicular variant of papillary thyroid cancer reveals low-risk noninvasive follicular thyroid neoplasm with papillary-like nuclear features: A paradigm shift to reduce aggressive treatment of indolent tumors
by: Nelson George, et al.
Published: (2018-01-01)

7. Fine needle aspiration cytology of thyroid nodules using The Bethesda system for reporting thyroid cytopathology.
by: Dr. Hitendra Barot, et al.
Published: (2020-12-01)

Malignancy rates for Bethesda III subcategories in thyroid fine needle aspiration biopsy (FNAB)
by: Leticia Mosca, et al.
Published: (2018-05-01)

The Bethesda system for reporting thyroid fine needle aspirates: A cytologic study with histologic follow-up
by: Santosh Kumar Mondal, et al.
Published: (2013-01-01)

Thyroid Fine-Needle Aspiration Cytology Practice in Korea
by: Yoon Jin Cha, et al.
Published: (2017-11-01)

Cannot write session to /tmp/vufind_sessions/sess_pcmvnv5ibrt7sk96vn6qtg4pcp